Freie Mitteilungen

Public health impact of statin prescribing strategies based on JUPITER in Switzerland

D. Nanchen (Lausanne)

Perkutane katheter-basierte Behandlung der schweren Mitralinsuffizienz - Erste Schweizer Erfahrungen mit dem MitraClip® System

M. Moccetti¹, D. Sürder², D. Hürlimann¹, C. Felix¹, F. Faletra², E. Pasotti², I. Bühler¹, J. Klimusina², T. F. Lüscher¹, T. Moccetti², J. Grünenfelder¹, G. Pedrazzini², R. Corti¹ (¹Zürich; ²Lugano)

Bruderholz - Disease Activity Score (BRU-DAS) as predictor of cardiovascular events: results of a 5 year follow-up observational cohort study

M. T. Gombert¹, P. Erzberger², M. Mutschelknauss², C. Jeanneret¹, B. C. Biedermann¹ (¹Bruderholz; ²Basel)

Interleukin Family Member ST2 and Mortality in Acute Dyspnea

T. Socrates¹, C. Defilippi², T. Reichlin¹, R. Twerenbold¹, T. Breidthardt¹, M. Noveanu¹, M. Potocki¹, M. Reiter¹, N. Arenja¹, C. Heinisch¹, J. Meissner¹, C. Jaeger¹, R. Christenson², C. Müller¹ (¹Basel; ²Baltimore USA)

Transmission von Influenza A/H1N1 auf einer Intensivstation

R. Tièche¹, P. Bachmann¹, R. J. Piso¹, R. Paganoni¹, C. Vonlanthen¹, S. Bassetti¹ (¹Olten)

Influenza surveillance using data from medical teleconsultations in Switzerland

E. Blozik¹, C. Grandchamp¹, J. Von Overbeck¹ (¹Basel)

Fear more Effectively Enhances Influenza Vaccination Rates in Nurses and Doctors than a 5 Year Long Intensive Campaign of Encouragement and Benefits

A. Friedl¹, C. Bloch¹, C. Agerter¹, J. H. Beer¹ (¹Baden)

Multidisciplinary care under one roof for IV drug users as a model for successful hepatitis C therapy

P. Bruggmann¹, M. Isler¹, L. Kravecz¹ (¹Zürich)

Should We Screen for Subclinical Hypothyroidism? An Individual Participant Data Analysis from 41,687 participants in Nine Prospective Cohort Studies on the Risk of Coronary Heart Disease and Mortality

N. Rodondi¹, W. Den Elzen², D. C. Bauer³, A. R. Cappola⁴, S. Razvi⁵, J. P. Walsh⁶, B. O. Asvold⁷, G. Iervasi⁸, M. Imaizumi⁹, P. Maisonneuve¹⁰, A. Bremner¹¹, M. Vanderpump¹², A. B. Newman¹³, J. Cornuz¹, J. A. Franklyn¹⁴, R. G. Westendorp², E. Vittinghoff³, J. Gussekloo² (¹Lausanne; ²Leiden; ³San Francisco; ⁴Philadelphia; ⁵Gateshead; ⁶Nedlands; ⁷Trondheim; ⁸Pisa; ⁹Nagasaki; ¹⁰Milano; ¹¹Crawley; ¹²London; ¹³Pittsburgh; ¹⁴Birmingham)

Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar state

S. Balanescu¹, N. Morgenthaler², P. Kopp³, M. B. Gaskill³, C. Schindler⁴, J. Rutishauser⁴ (¹Lausanne; ²Henningsdorf DE; ³Chicago USA; ⁴Basel)

Extraintestinal Manifestations in Inflammatory Bowel Disease: Frequency and Risk Factors in 950 Patients of the Nationwide Swiss IBD Cohort Study

S. Vavricka¹, L. Brun¹, P. Ballabeni², V. Pittet², M. B. P. Vavricka¹, G. Rogler¹, A. M. Schoepfer³ (¹Zürich; ²Lausanne; ³Bern)

Ficolin-2, a new serum marker that strongly correlates with disease activity in Crohn’s disease

F. Seibold¹, T. Schaffer¹, S. Müller¹ (¹Bern)